Akebia Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Akebia Therapeutics Inc
TickerAKBA
CIK #0001517022
CUSIP00972D105
SectorLife Sciences - Pharmaceutical Preparations
Address245 First Street Suite 1100, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2025
[0001517022] 10-K
[0001517022] 10-Q
[0001517022] 3
[0001517022] 4
[0001517022] 5
[0001517022] 8-K
[0001517022] SC 13D
[0001517022] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Akebia Therapeutics Inc [2025-04-30] 0.0
BlackRock Inc Akebia Therapeutics Inc [2024-11-08] 7.2
BlackRock Inc Akebia Therapeutics Inc [2024-10-22] 7.2
Satter Muneer A Akebia Therapeutics Inc [2022-12-19] 7.5
BlackRock Inc Akebia Therapeutics Inc [2022-07-08] 2.4
State Street Corp Akebia Therapeutics Inc [2021-02-11] 15.55
Vanguard Group Inc Akebia Therapeutics Inc [2021-02-10] 5.84
Wellington Management Group LLP Akebia Therapeutics Inc [2020-11-10] 12.35
Nantahala Capital Management LLC Akebia Therapeutics Inc [2020-02-13] 5.7
Baupost Group LLC/MA Akebia Therapeutics Inc [2019-01-09] 20.94
Abrams Capital Management LP Akebia Therapeutics Inc [2018-12-07] 0.0
Nantahala Capital Management LLC Akebia Therapeutics Inc [2018-09-26] 0.8
Novo Holdings A/S Akebia Therapeutics Inc [2018-02-13] 5.25
Satter Muneer A Akebia Therapeutics Inc [2017-07-14] 6.48
Vifor Pharma Ltd Akebia Therapeutics Inc [2017-05-22] 8.4
Nantahala Capital Management LLC Akebia Therapeutics Inc [2017-02-14] 5.8
FMR LLC Akebia Therapeutics Inc [2016-02-12] 0.0
BlackRock Inc Akebia Therapeutics Inc [2016-01-28] 5.5
Satter Muneer A Akebia Therapeutics Inc [2015-02-12] 7.8
Venture Investors Early Stage Fund IV LP Akebia Therapeutics Inc [2015-02-09] 5.7
Eagle Asset Management Inc Akebia Therapeutics Inc [2015-01-06] 6.01
Triathlon Medical Ventures Fund LP Akebia Therapeutics Inc [2014-04-29] 5.8
Novo A/S Akebia Therapeutics Inc [2014-04-03] 7.5
Novartis BioVentures Ltd Akebia Therapeutics Inc [2014-03-31] 16.81
Kearny Venture Partners LP Akebia Therapeutics Inc [2014-03-28] 5.6
Form 3/4/5 Filer 2011 - 2025
Akebia Therapeutics, Inc.
Ostrowski Erik
Zumwalt Leanne M
Malabre Richard C
Frieson Ron
Gilman Steven C
Rogers Michael W
Smith Cynthia
Wolf Myles
Adams Adrian
Burke Steven Keith
Butler John P.
Grund Nicholas
Dahan Michel
Hadas Nicole R.
Snow Ellen
Spellman David A
Cotreau Violetta
Faulkingham Dell
Heffernan Michael Thomas
Gowen Maxine
Enyedy Mark J
Tubridy Karen L
Amello Jason
Canute Scott A
Morrison Jodie Pope
Jain Rita
Wyzga Michael S
Satter Muneer A
Renaud Ronald C JR
Nash Duane
Clayman Michael D.
Maroni Bradley
Dalal Anupam
Shalwitz Robert
Novartis Bioventures Ltd
Novo Holdings A/S
Adox James R
Viesf IV GP LLC
Venture Investors LLC
Venture Investors Southeast LLC
Weiss Paul M
Peterson Loren G
Button Scott
Arida George
NEIS John
Venture Investors Early Stage Fund IV LP
Ganser Roger H
Nielsen Jack
Dueholm Kim
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 17,923,424 18,373,961
Vanguard Group Inc [2025-06-30] SOLE 0 14,354,498
State Street Corp [2025-06-30] DFND 7,655,291 7,997,153
Geode Capital Management LLC [2025-06-30] DFND 6,074,458 6,074,458
Morgan Stanley [2025-06-30] DFND 4,361,067 5,339,654
Renaissance Technologies LLC [2025-06-30] SOLE 4,194,427 4,194,427
Goldman Sachs Group Inc [2025-06-30] DFND 3,933,432 3,934,002
MPM BioImpact LLC [2025-06-30] SOLE 2,889,125 2,889,125
Nuveen, LLC [2025-06-30] DFND 2,700,981 2,708,676
Franklin Resources Inc [2025-06-30] DFND 2,665,386 2,667,412
Citadel Advisors LLC [2025-06-30] DFND 2,541,590 2,541,590
Millennium Management LLC [2025-06-30] SOLE 2,163,499 2,163,499
Northern Trust Corp [2025-06-30] DFND 2,095,638 2,095,638
Nantahala Capital Management LLC [2025-06-30] SOLE 2,000,000 2,000,000
Great Point Partners LLC [2025-06-30] SOLE 0 1,985,915
Affinity Asset Advisors LLC [2025-06-30] SOLE 1,950,000 1,950,000
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,714,544 1,714,544
JPMorgan Chase & Co [2025-06-30] DFND 1,417,321 1,652,746
Informed Momentum Co LLC [2025-06-30] SOLE 564,058 1,454,328
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 1,112,205 1,205,128
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 1,180,759 1,180,759
Bank of America Corp /DE/ [2025-06-30] DFND 103,237 1,110,480
Woodline Partners LP [2025-06-30] SOLE 1,001,360 1,001,360
Susquehanna International Group LLP [2025-06-30] OTR 791,352 930,352
Dimensional Fund Advisors LP [2025-06-30] SOLE 685,341 861,816
FMR LLC [2025-06-30] DFND 805,846 813,982
Charles Schwab Investment Management Inc [2025-06-30] SOLE 749,015 749,015
Wellington Management Group LLP [2025-06-30] DFND 0 695,728
UBS Group AG [2025-06-30] DFND 596,962 639,462
Federated Hermes Inc [2025-06-30] DFND 617,318 617,318
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com